2020
DOI: 10.1111/ner.13067
|View full text |Cite
|
Sign up to set email alerts
|

A Review of Clinical Data on Salvage Therapy in Spinal Cord Stimulation

Abstract: Background: Since its introduction in 1967, neuromodulation through spinal cord stimulation (SCS) or dorsal root ganglion stimulation (DRGs) has advanced significantly in both the technology and indications for use. There are now over 14,000 SCS implants performed worldwide every year. This review focuses on mechanisms behind the loss of efficacy in neuromodulation and current data on salvage therapy, defined as the conversion of a neuromodulation device to an alternative SCS or DRG stimulation, in the event o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(27 citation statements)
references
References 43 publications
0
27
0
Order By: Relevance
“…Studies should also investigate the mechanism of action of analgesia and decreased opioid consumption after burst and tonic stimulation. Finally, studies should examine whether burst stimulation is a good option for salvage therapy in nonresponders to tonic stimulation (30).…”
Section: Discussionmentioning
confidence: 99%
“…Studies should also investigate the mechanism of action of analgesia and decreased opioid consumption after burst and tonic stimulation. Finally, studies should examine whether burst stimulation is a good option for salvage therapy in nonresponders to tonic stimulation (30).…”
Section: Discussionmentioning
confidence: 99%
“…It is known that habituation phenomena with SCS manifest across time in various patients and pain conditions. There is early and limited evidence that suggests that DRGS may prove to be a beneficial salvage strategy in patients that lose SCS efficacy in the long term (15,16). In our review, we found: (10/28) mentioned failed conventional management without detailed description of specific treatments (17–25), (7/28) failed to mention the failure of early management (26–32), (3/28) reported patients failing pharmacological management only (33–35), and (9/28) detail specific failed early management therapies prior to DRGS treatment (25,36–43).…”
Section: Resultsmentioning
confidence: 99%
“…Patients undergoing explantation of their t‐SCS devices is not uncommon; up to 30% of patients undergo explantation over the course of over a decade 23 . There is no consensus on what the next best option should be for this significant patient population, who are often left with suboptimal pain control 24 . The results of this single‐center, small retrospective investigation suggest that 10‐kHz SCS therapy can effectively reduce chronic pain intensity and increase functionality in those individuals with FBSS and CRPS who had a limited long‐term response to t‐SCS therapy.…”
Section: Discussionmentioning
confidence: 99%